MDXG PEER ANALYSIS

MiMedx Group Inc — metric-by-metric comparison with peers and the industry median

MDXGMiMedx Group Inc

🇺🇸 USA · NASDAQ · Healthcare · Biotechnology

Value it Duel

Overall Profile & Returns

· Biotechnology

Position Within Industry

0 = weak quartile, 100 = strong quartile

MDXGIndustry median

Scores normalize each metric against industry quartiles (p25–p75); direction is inverted for lower-is-better metrics.

Return Comparison

1-Year

Split-adjusted

Year-to-Date (YTD)

Key Metric Comparison

P/E

Lower is better

ROE

Higher is better

Net Margin

Higher is better

Revenue Growth

Higher is better

All Metrics

Valuation
Metric	MDXG	MSB	TLX	RTALB	CSL	Ind. Median
P/E	20.31	—	—	4.78●	29.96	18.06
P/B	2.57	—	6.38	0.59●	2.24	3.62
EV/EBITDA	8.41●	—	120.20	72.98	10.35	15.13
P/S	1.60●	31.30	3.24	6.52	2.66	10.65

Financial Health
Metric	MDXG	MSB	TLX	RTALB	CSL	Ind. Median
Current Ratio	5.39●	—	1.43	1.21	2.57	5.90
Debt/Equity	7.2%	—	112.3%	1.2%●	67.4%	10.9%
NetDebt/EBITDA	-2.48●	—	13.13	0.90	2.22	1.15

Profitability
Metric	MDXG	MSB	TLX	RTALB	CSL	Ind. Median
Net Margin	7.9%	-115.3%	-0.9%	136.3%●	9.2%	-125.7%
ROE	13.8%	-11.3%	-1.8%	15.1%●	7.7%	-47.5%
ROA	10.6%	-8.6%	-0.7%	13.1%●	3.8%	-35.8%
EBITDA Margin	14.7%	-76.6%	3.0%	9.0%	32.8%●	-105.8%

Growth + Dividend
Metric	MDXG	MSB	TLX	RTALB	CSL	Ind. Median
Rev. Growth	10.5%	410.4%●	56.3%	24.0%	4.8%	5.1%
NI Growth	-23.6%	—	—	134.0%●	-39.4%	12.1%
Div. Yield	—	0.0%	—	0.0%	2.5%●	0.2%
Payout	—	0.0%	—	0.0%	103.1%	0.0%

Valuation
Metric	MDXG	OMER	ZURA	DNA	ARVN	PRTA	Ind. Median
P/E	20.31	—	—	—	—	—	18.06
P/B	2.57	-10.36●	2.63	1.26	1.42	1.68	3.62
EV/EBITDA	8.41	—	—	—	—	—	15.13
P/S	1.60●	—	—	3.94	6.15	9.04	10.65

Financial Health
Metric	MDXG	OMER	ZURA	DNA	ARVN	PRTA	Ind. Median
Current Ratio	5.39	3.03	19.33●	5.15	5.44	10.43	5.90
Debt/Equity	7.2%	-490.5%●	—	92.7%	2.2%	2.4%	10.9%
NetDebt/EBITDA	-2.48●	—	—	-0.18	2.80	4.31	1.15

Profitability
Metric	MDXG	OMER	ZURA	DNA	ARVN	PRTA	Ind. Median
Net Margin	7.9%●	—	—	-215.4%	-247.5%	-260.9%	-125.7%
ROE	13.8%●	—	-42.5%	-55.8%	-42.3%	-40.3%	-47.5%
ROA	10.6%●	—	-37.6%	-26.2%	-26.8%	-35.8%	-35.8%
EBITDA Margin	14.7%●	—	—	-149.2%	-242.2%	-129.0%	-105.8%

Growth + Dividend
Metric	MDXG	OMER	ZURA	DNA	ARVN	PRTA	Ind. Median
Rev. Growth	10.5%●	—	-100.0%	-40.5%	-79.1%	-58.0%	5.1%
NI Growth	-23.6%	—	—	—	—	—	12.1%
Div. Yield	—	—	—	—	—	—	0.2%
Payout	—	—	—	—	—	—	0.0%

The green dot marks the best value in the group given the metric direction (higher/lower is better). All metrics use trailing-twelve-month (TTM) data.

Go deeper on MDXG

Run a DCF valuation

Full DCF model with editable assumptions

Start a head-to-head duel

Compare two stocks metric by metric

Filter in the stock screener

Build your own universe with 400+ metrics

Data on this page refreshes once per day. Price data as of Jul 7, 26. This content is for informational purposes only and is not investment advice.